CRL-1420 MIAPaCa-2 胰腺癌細胞系

]資料

點擊看大圖

如果您對該產品感興趣的話,可以

產品名稱: CRL-1420 MIAPaCa-2 胰腺癌細胞系
產品型號: CRL-1420
產品廠商: 進口
產品文檔: 無相關文檔

簡單介紹

CRL-1420 MIAPaCa-2 胰腺癌細胞系，ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞；細胞庫管理規范，提供的細胞株背景清楚，提供參考文獻和培養條件！

CRL-1420 MIAPaCa-2 胰腺癌細胞系的詳細介紹

CRL-1420 MIAPaCa-2 胰腺癌細胞系

ATCC^® Number:

CRL-1420?

Price:

$279.00

Designations:	MIA PaCa-2
Depositors:	A Yunis
Biosafety Level:	1
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	adherent, single cells and loosely attached clusters
Organism:	Homo sapiens (human)
Morphology:	attached epithelial with floating rounded cells
Source:	Organ: pancreas Disease: carcinoma
Cellular Products:	human colony stimulating factor, subclass I (CSF-I); plasminogen activator
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Isolation:	Isolation date: 1975
DNA Profile (STR):	Amelogenin: X CSF1PO: 10 D13S317: 12,13 D16S539: 10,13 D5S818: 12,13 D7S820: 12,13 THO1: 9,10 TPOX: 9 vWA: 15
Cytogenetic Analysis:	This is a hypotriploid human cell line. The modal chromosome number is 61. Sixteen to 20 marker chromosomes are commonly found in a cell. A few normal chromosomes are absent.
Isoenzymes:	G6PD, B
Age:	65 years
Gender:	male
Ethnicity:	Caucasian
Comments:	The MIA PaCa-2 cell line was established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male. [58034] The established cell line reportedly has a doubling time of about 40 hours and a colony-forming efficiency in soft agar of approximately 19%. [58034] Hybridomas have been made against the CSF-I produced by this line ATCC HB-8207 (F1A3-23) and ATCC HB-8208 (F18 AF1). The line is sensitive to asparaginase.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%; horse serum to a final concentration of 2.5%. Temperature: 37.0°C
Subculturing:	Protocol: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks. Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended Medium Renewal: 2 to 3 times per week
Preservation:	Freeze medium: Complete growth medium 95%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase
Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002 recommended serum:ATCC 30-2020 recommended serum:ATCC 30-2040
References:	1057: Wu M, et al. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 16: 1908-1913, 1977. PubMed: 15590 22291: Fountzilas G, et al. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2). J. Natl. Cancer Inst. 76: 37-43, 1986. PubMed: 3455740 49623: Robertson JF, et al. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer. Int. J. Cancer 63: 69-75, 1995. PubMed: 7558455 58034: Yunis AA, et al. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int. J. Cancer 19: 128-135, 1977. PubMed: 832918

ATCC^® Number:

CRL-1420?

Price:

$279.00

Designations:	MIA PaCa-2
Depositors:	A Yunis
Biosafety Level:	1
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	adherent, single cells and loosely attached clusters
Organism:	Homo sapiens (human)
Morphology:	attached epithelial with floating rounded cells
Source:	Organ: pancreas Disease: carcinoma
Cellular Products:	human colony stimulating factor, subclass I (CSF-I); plasminogen activator
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Isolation:	Isolation date: 1975
DNA Profile (STR):	Amelogenin: X CSF1PO: 10 D13S317: 12,13 D16S539: 10,13 D5S818: 12,13 D7S820: 12,13 THO1: 9,10 TPOX: 9 vWA: 15
Cytogenetic Analysis:	This is a hypotriploid human cell line. The modal chromosome number is 61. Sixteen to 20 marker chromosomes are commonly found in a cell. A few normal chromosomes are absent.
Isoenzymes:	G6PD, B
Age:	65 years
Gender:	male
Ethnicity:	Caucasian
Comments:	The MIA PaCa-2 cell line was established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male. [58034] The established cell line reportedly has a doubling time of about 40 hours and a colony-forming efficiency in soft agar of approximately 19%. [58034] Hybridomas have been made against the CSF-I produced by this line ATCC HB-8207 (F1A3-23) and ATCC HB-8208 (F18 AF1). The line is sensitive to asparaginase.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%; horse serum to a final concentration of 2.5%. Temperature: 37.0°C
Subculturing:	Protocol: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks. Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended Medium Renewal: 2 to 3 times per week
Preservation:	Freeze medium: Complete growth medium 95%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase
Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002 recommended serum:ATCC 30-2020 recommended serum:ATCC 30-2040
References:	1057: Wu M, et al. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 16: 1908-1913, 1977. PubMed: 15590 22291: Fountzilas G, et al. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2). J. Natl. Cancer Inst. 76: 37-43, 1986. PubMed: 3455740 49623: Robertson JF, et al. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer. Int. J. Cancer 63: 69-75, 1995. PubMed: 7558455 58034: Yunis AA, et al. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int. J. Cancer 19: 128-135, 1977. PubMed: 832918

ATCC® Number: CRL-1420? Price: $279.00
Designations: MIA PaCa-2
Depositors: A Yunis
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: adherent, single cells and loosely attached clusters
Organism: Homo sapiens (human)
Morphology: attached epithelial with floating rounded cells

Source: Organ: pancreas
Disease: carcinoma
Cellular Products: human colony stimulating factor, subclass I (CSF-I); plasminogen activator
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Isolation: Isolation date: 1975
DNA Profile (STR): Amelogenin: X
CSF1PO: 10
D13S317: 12,13
D16S539: 10,13
D5S818: 12,13
D7S820: 12,13
THO1: 9,10
TPOX: 9
vWA: 15
Cytogenetic Analysis: This is a hypotriploid human cell line. The modal chromosome number is 61. Sixteen to 20 marker chromosomes are commonly found in a cell. A few normal chromosomes are absent.
Isoenzymes: G6PD, B
Age: 65 years
Gender: male
Ethnicity: Caucasian
Comments: The MIA PaCa-2 cell line was established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male. [58034]
The established cell line reportedly has a doubling time of about 40 hours and a colony-forming efficiency in soft agar of approximately 19%. [58034]
Hybridomas have been made against the CSF-I produced by this line ATCC HB-8207 (F1A3-23) and ATCC HB-8208 (F18 AF1).
The line is sensitive to asparaginase.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%; horse serum to a final concentration of 2.5%.
Temperature: 37.0°C
Subculturing: Protocol: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended
Medium Renewal: 2 to 3 times per week
Preservation: Freeze medium: Complete growth medium 95%; DMSO, 5%
Storage temperature: liquid nitrogen vapor phase
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
recommended serum:ATCC 30-2020
recommended serum:ATCC 30-2040
References: 1057: Wu M, et al. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 16: 1908-1913, 1977. PubMed: 15590
22291: Fountzilas G, et al. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2). J. Natl. Cancer Inst. 76: 37-43, 1986. PubMed: 3455740
49623: Robertson JF, et al. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer. Int. J. Cancer 63: 69-75, 1995. PubMed: 7558455

產品留言

標題

聯系人

聯系電話

內容

驗證碼

點擊換一張

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發送信息!
2.如有必要,請您留下您的詳細聯系方式!

相關產品

3T3D 人骨髓瘤細胞 3T3D 人骨髓瘤細胞

HTB-120 NCI-H128 人肺小細胞肺癌細胞 HTB 120 NCI H128

HTB-119 NCI-H69 [H69]人肺小細胞肺癌細胞 HTB-119

HS77 人肺小細胞肺癌細胞 HS77

D6 人肺腺癌細胞 D6

聯系我們



 	電      話：021-35080510

 手       機: 15000266580（微信同步）

 菌種Q Q ： 316826860

 細胞Q Q ：1784382136

  
 

 
 	菌種Q Q:1623059823 
 
 Email：xiangfbio@163.com

產品搜索

細胞系，ATCC細胞，ATCC菌種，細胞系目錄，ATCC，鼠傷寒沙門氏菌，atcc細胞庫，人**瘤細胞，人食管癌細胞，ATCC 19404，ATCC 25922，ATCC 19146，微生物菌種，細胞株，標準菌株，ATCC中國，atcc上海代理，CMCC 菌株，ATCC菌株，細胞目錄，質控菌株，腫瘤細胞株，乳腺癌細胞系，人肝癌細胞系

產品目錄